Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
Overcoming Vaccine Hesitancy: The Role of the First 5 Minutes Approach
Emerging Bronchoscopic Treatments for COPD: A Review of Clinical Trials
Jonathan Kurman, MD
PeerApplying the First 5 Minutes Concept to COPD Care
Pulmonary Hypertension in COPD: Insights into Diagnosis and Treatment
Arun Jose, MD
PeerGOLD Guidelines for COPD Care: Evolving Strategies for Exacerbation Prevention
Brian Bizik, MS, PA-C
PeerThe Impact of High-Intensity Noninvasive Ventilation in COPD Management
Alejandra Lastra, MD
PeerTargeting NETs: A New Frontier in COPD Treatment